PDB25 COST OF ALL-CAUSE AND CARDIOVASCULAR DISEASE-RELATED HOSPITALIZATION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE BID, SULFONYLUREAS, OR INSULIN- A RETROSPECTIVE ANALYSIS OF THE LIFELINK DATABASE
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.533
https://www.valueinhealthjournal.com/article/S1098-3015(11)00672-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1095
First Page :
A95
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00672-3&doi=10.1016/j.jval.2011.02.533